이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Emergent BioSolutions 관리
관리 기준 확인 0/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Joe Papa
최고 경영자
n/a
총 보상
| CEO 급여 비율 | n/a |
| CEO 임기 | less than a year |
| CEO 소유권 | n/a |
| 경영진 평균 재임 기간 | 1.3yrs |
| 이사회 평균 재임 기간 | 2.9yrs |
최근 관리 업데이트
Recent updates
Emergent BioSolutions: High-Risk, High-Reward Strategic Turnaround
May 10New CEO Appointment A Clear Positive For Emergent BioSolutions
Feb 27Emergent BioSolutions: Q3 Numbers Leave Work To Be Done
Dec 18Emergent BioSolutions: Meaningful Debt, But Narcan Should Grow
Nov 23Emergent BioSolutions Is Clearly Risky, But The Reward Could Be Substantial
Aug 23Financial Woes Darken Emergent BioSolutions' Outlook (Rating Downgrade)
Aug 14Emergent BioSolutions: Making A Big Bet On Narcan
Jul 21An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 30% Undervalued
Jun 22
Is Emergent BioSolutions (NYSE:EBS) Using Too Much Debt?
Apr 05Emergent Biosolutions Q4 2022 Earnings Preview
Feb 24An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 39% Undervalued
Feb 16Emergent BioSolutions to offload travel health business to Bavarian Nordic for $380M
Feb 15Emergent BioSolutions: No Change To Thesis Following Latest Numbers, Recent Developments
Dec 07Emergent plunges 30% on quarterly earnings miss, lowers full-year guidance
Nov 09Emergent doses first participant in Phase 1 trial for Lassa virus vaccine
Sep 06Emergent BioSolutions: Now Long Through Sale Of October Put Spreads
Aug 24A Look At The Fair Value Of Emergent BioSolutions Inc. (NYSE:EBS)
Aug 13Additional 135M COVID-19 vaccine doses destroyed at Emergent BioSolutions Baltimore plant
Aug 12Emergent BioSolutions misses on top and bottom lines as it swings to quarterly loss
Aug 01Moderna 2.0: 3 Stocks To Play The Potential Monkeypox Pandemic
Jul 26Emergent BioSolutions (NYSE:EBS) Takes On Some Risk With Its Use Of Debt
Jul 26Kamada inks $11.4 M supply deal for chickenpox preventive antibody Varizig
Jul 06Emergent BioSolutions: A Top Pick For The Monkeypox Outbreak
May 29Emergent BioSolutions Inc. (NYSE:EBS) Shares Could Be 37% Below Their Intrinsic Value Estimate
May 12CEO
Joe Papa (68 yo)
less than a year
테뉴어
Mr. Joseph C. Papa, Jr. also known as Joe, serves as Executive Advisor at Water Street Healthcare Partners, LLC since joining in June 13, 2023. He serves as Chairman at SparingVision SAS since March 2023....
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Executive VP | 6.3yrs | US$2.18m | 0.30% $ 945.4k | |
| Executive VP of External Affairs | 1.3yrs | US$2.13m | 0.33% $ 1.0m | |
| Executive Vice President of Global Quality and Ethics & Compliance | 2.2yrs | US$1.68m | 0.31% $ 988.6k | |
| Senior Vice President of Products Business | 1.4yrs | US$1.06m | 0.047% $ 148.0k | |
| CEO, President & Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Senior VP & Chief Human Resource Officer | 1.3yrs | 데이터 없음 | 데이터 없음 | |
| Senior VP | 1.3yrs | 데이터 없음 | 데이터 없음 | |
| Senior VP of Science & Development | 1.4yrs | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Manufacturing & Bioservices | no data | 데이터 없음 | 0.063% $ 200.6k |
1.3yrs
평균 재임 기간
57yo
평균 연령
경험이 풍부한 관리: EBS 의 관리팀은 경험 (평균 재직 기간 1.3 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, President & Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Independent Director | 18yrs | US$400.23k | 0.10% $ 323.7k | |
| Independent Director | 19.4yrs | US$394.73k | 0.038% $ 120.2k | |
| Independent Director | less than a year | US$397.50k | 데이터 없음 | |
| Independent Director | 2.2yrs | US$396.99k | 0.011% $ 34.7k | |
| Independent Director | 3.7yrs | US$405.98k | 0.033% $ 103.7k | |
| Independent Non-Executive Chairman | 19.8yrs | US$535.98k | 0.073% $ 230.6k | |
| Independent Director | 7.6yrs | US$413.48k | 0.071% $ 224.5k | |
| Independent Director | less than a year | US$398.75k | 데이터 없음 | |
| Independent Director | 1.9yrs | US$382.23k | 0.0075% $ 23.9k |
2.9yrs
평균 재임 기간
65yo
평균 연령
경험이 풍부한 이사회: EBS 의 이사회는 경험(평균 재직 기간 2.9 년)으로 간주되지 않으므로 새 이사회가 필요합니다.